Business

OncoSil Selected for Major European Pancreatic Cancer Study

OncoSil Selected for Major European Pancreatic Cancer Study

Oncosil Medical LtdJuly 1, 20263

OncoSil Selected for Major European Pancreatic Cancer Study

About this update from Oncosil Medical Ltd

Oncosil Medical Ltd has released a press release. View Attachment

View stock analysis, news, and events for Oncosil Medical Ltd

More from Oncosil Medical Ltd

OSL Secures $5.6 million from Major Institutional Investors

September 7, 2026

OncoSil Receives FDA Approval for Distal Cholangiocarcinoma

August 16, 2026

All Oncosil Medical Ltd news →